{"schema_version":"1.0","type":"article","title":"羅氏花4億美元，包下翰森的ADC工廠","url":"https://drugnews.com.tw/articles/2026-10-29-hansoh-roche-adc-platform-deal.html","markdown_url":"https://drugnews.com.tw/articles/2026-10-29-hansoh-roche-adc-platform-deal.md","lang":"zh-Hant","date":"2026-10-29","publish_at":"2026-10-29T20:00:00+08:00","updated_at":"2026-10-29","category":"商業分析系列","topic":"BD / 授權","tags":["翰森製藥","羅氏 Roche","ADC","中國授權","全球醫藥交易"],"summary":"翰森 10/19 與羅氏簽 ADC 合作：首付 4 億美元、頭條逾 155 億美元。羅氏指定靶點、翰森用平台做到 Ia 期，首付比一年前買單顆藥高五倍——羅氏買的是研發產能。","key_points":["翰森製藥 2026-10-19 公告與羅氏簽 ADC 戰略合作及授權：首付 4 億美元、一週年 1.1 億美元、里程碑逾 150 億美元，頭條總額逾 155 億美元。","合作包含翰森兩個臨床前 ADC 項目與羅氏指定靶點的新項目，翰森做到全球 Ia 期後由羅氏接手大中華區以外開發；2025 年 10 月羅氏買翰森一期 CDH17 ADC HS-20110 的首付是 8,000 萬美元。","同模式的 Genentech × 映恩生物（2026 年 8 月）首付 4,500 萬美元。"],"facts":[],"sections":["01｜羅氏到底買到什麼？","02｜為什麼早期項目，首付反而高五倍？","03｜頭條 155 億美元，真正確定的是多少？","04｜這對誰是好消息、對誰是壓力？","參考資料"],"references":[{"title":"翰森製藥再度攜手羅氏拓展 ADC 合作 潛在 BD 交易金額超 155 億美元","source":"新浪財經","date":"2026-10-19","url":"https://cj.sina.com.cn/articles/view/2868676035/aafc85c302001yrke"},{"title":"Roche picks cancer targets, Hansoh builds the ADCs in deal with $400 million upfront","source":"Drug Discovery & Development","date":"2026-10-19","url":"https://www.drugdiscoverytrends.com/roche-picks-cancer-targets-hansoh-builds-the-adcs-in-deal-with-400-million-upfront/"},{"title":"Roche Inks Another China ADC Pact With $1.5B Hansoh Bet","source":"BioSpace","date":"2025-10-17","url":"https://www.biospace.com/deals/roche-inks-another-china-adc-pact-with-1-5b-hansoh-bet"},{"title":"翰森製藥公告","source":"翰森製藥","date":"2026-10-19","url":"https://www.hansoh.cn/news/news-detail-514090.htm"}],"images":[{"alt":"這一年，大藥廠向中國藥廠付出的首付","url":"https://drugnews.com.tw/assets/articles/hansoh-roche-adc-platform-deal/figure-01.png"},{"alt":"羅氏與翰森的分工","url":"https://drugnews.com.tw/assets/articles/hansoh-roche-adc-platform-deal/figure-02.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/hansoh-roche-adc-platform-deal/cover.png","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-10-29）。羅氏花4億美元，包下翰森的ADC工廠。https://drugnews.com.tw/articles/2026-10-29-hansoh-roche-adc-platform-deal.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}